Cerbios-Pharma SA
Pharmaceutical ManufacturingTicino, Switzerland51-200 Employees
Cerbios-Pharma SA is a Swiss pharmaceutical contract development and manufacturing organization that integrates chemical, biological, and high-potency manufacturing, supported by facilities in Lugano, Ticino, and Couvet, Neuchâtel, as part of the HAS Group. It provides end-to-end development and manufacturing for APIs, HPAPIs, payloads, ADCs, proteins, and antibodies, and its Proveo division offers integrated ADC services from payload synthesis through conjugation, with CMC and regulatory support. Its established portfolio includes reduced folates and vitamin D analogues, and the company is active in HPAPI production and probiotics, including its Enterococcus faecium SF68 strain. It also supplies animal health probiotic additives under the Cernivet line for livestock and pets. Cerbios emphasizes Swiss precision and global delivery from clinical development to commercial supply for partners worldwide, and in 2021 it launched SF68 SKINActive, a probiotic-based treatment for skin disorders.